KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, launched of KBI PUREplatform, a microbial cell line development (CLD) platform designed to create efficiencies in a microbial expression system for biopharmaceutical production. The platform addresses industry challenges such as low titers, poor product quality, and capacity constraints, and aims to help customers significantly improve processes. Engineered for commercial use, the platform features KBI’s PUREcoli high-producing E. coli c...